Braftovi Interactions
There are 628 drugs known to interact with Braftovi (encorafenib), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 278 are major, 339 are moderate, and 11 are minor.
- View all 628 medications that may interact with Braftovi
- View Braftovi alcohol/food interactions (1)
- View Braftovi disease interactions (5)
Most frequently checked interactions
View interaction reports for Braftovi (encorafenib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Aldurazyme (laronidase)
- Amicar (aminocaproic acid)
- amoxicillin
- Aubagio (teriflunomide)
- Austedo (deutetrabenazine)
- biotin
- Blincyto (blinatumomab)
- Brineura (cerliponase alfa)
- Caprelsa (vandetanib)
- Cerdelga (eliglustat)
- famotidine
- Imbruvica (ibrutinib)
- levothyroxine
- lisinopril
- Mektovi (binimetinib)
- melatonin
- Pomalyst (pomalidomide)
- Pradaxa (dabigatran)
- Prolia (denosumab)
- Rexulti (brexpiprazole)
- Soliris (eculizumab)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tarceva (erlotinib)
- Tecfidera (dimethyl fumarate)
- Valium (diazepam)
- Vitamin D3 (cholecalciferol)
Braftovi alcohol/food interactions
There is 1 alcohol/food interaction with Braftovi (encorafenib).
Braftovi disease interactions
There are 5 disease interactions with Braftovi (encorafenib) which include:
Report options
QR code containing a link to this page
More about Braftovi (encorafenib)
- Braftovi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
